AI Article Synopsis
- This study investigates how different antihypertensive medications affect the risk of periodontitis using a method called Mendelian randomization (MR).
- It analyzes nine types of antihypertensive drugs to see their long-term impacts on both acute and chronic periodontitis, using genetic data linked to these medications and blood pressure traits.
- The results suggest that while angiotensin-converting enzyme inhibitors may increase the risk of acute periodontitis, loop diuretics could lower the risk of chronic forms, highlighting the complexity of drug interactions and their effects on dental health.
Article Abstract
Objective: The aim of this study was to elucidate the nuanced interactions between antihypertensive medications and the risk of periodontitis using the Mendelian randomization analysis method.
Method And Materials: The study adopted a drug-target Mendelian randomization method to assess the long-term effects of nine antihypertensive drug categories on the risk of periodontitis in both acute and chronic cases. Genetic variants located in or near genes relevant to the targets of these drugs and associated with systolic blood pressure (SBP) were selected to simulate the influence of antihypertensive treatments. Genetic information on SBP and periodontitis susceptibility was extracted from extensive genome-wide association studies for both acute and chronic conditions. Additionally, a secondary analysis was conducted using expression quantitative trait loci for the genes of interest as alternative proxies. Colocalization analysis was performed to explore shared variants between antihypertensive drugs and periodontitis.
Results: The analysis revealed that the use of angiotensin-converting enzyme inhibitors with an increased risk of acute periodontitis (odds ratio (OR) [95% confidence interval] 1.43 [1.11, 1.85] per 1 mmHg reduction in SBP; P = 5.93 × 10-3) and loop diuretics with a decreased risk of chronic periodontitis (OR 0.94 [0.90, 0.98]; P = 2.94 × 10-3). Moreover, genetically mimicking the use of a suggestive protective effect of thiazides and related diuretics on acute periodontitis was observed in both acute (OR 0.95 [0.90, 0.99]; P = .021) and chronic (OR 0.98 [0.97, 1.00]; P = .045) periodontitis. Colocalization analysis revealed antihypertensive drugs and periodontitis shared causal variants in ACE and SLC12A2 locus.
Conclusion: The research indicates that loop diuretics might decrease the risk of periodontitis, while angiotensin-converting enzyme inhibitors could heighten the risk. Further investigations are required to evaluate the potential of reusing antihypertensive drugs for periodontitis prevention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3290/j.qi.b5754882 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects.
Drug Des Devel Ther
January 2025
Clinical Trial Center, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, 313000, People's Republic of China.
Purpose: The study aimed to investigate the pharmacokinetics and bioequivalence of coformulations of valsartan and amlodipine in healthy Chinese subjects under both fasting and fed conditions.
Methods: The research was conducted under both fasting and fed studies and employed a single-center, randomized, open-label, single-dose, three-period design with partial-repeat and crossover elements. A total of 71 healthy Chinese adult participants were included under fasting (n = 36) and fed (n = 35) conditions.
Antihypertensive strategies for the prevention of secondary stroke: a systematic review and meta-analysis.
Eur J Med Res
January 2025
West China School of Nursing, Sichuan University, Chengdu, 610041, Sichuan, China.
Background: Stroke is an important contributor to disability and death globally. Hypertension is a main risk factor for recurrent stroke in patients with ischemic and hemorrhagic stroke or transient ischemic attack. Higher systolic blood pressure, diastolic blood pressure, pulse pressure and mean arterial pressure at admission are independently associated with the risk of stroke recurrence.
View Article and Find Full Text PDFPostdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension.
BMC Cancer
January 2025
Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Background: Arterial hypertension is one of the most frequent comorbidities in patients with cancer. Studies have indicated that drugs used to control hypertension may alter cancer patient survival; however, epidemiological findings for their impact on cancer survival remain inconsistent. The aim of this study was to examine the effect of the consumption of antihypertensive (AH) medication on the risk of death in cancer patients.
View Article and Find Full Text PDFInclusion Complex of Nimodipine with Sulfobutylether-β-cyclodextrin: Preparation, Characterization, In Vitro and In Vivo Evaluation.
AAPS PharmSciTech
January 2025
Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350108, China.
Nimodipine (NIMO) is used to treat ischemic nerve injury from subarachnoid hemorrhage (SAH), but its low aqueous solubility limits clinical safety and bioavailability. This study aims to improve NIMO's solubility by preparing inclusion complexes with sulfobutylether-β-cyclodextrin (SBE-β-CD), reducing the limitations of Nimotop injection, including vascular irritation, toxicity, and poor dilution stability. The NIMO-SBE-β-CD inclusion complex (NIMO-CD) was characterized in both liquid and solid states through phase solubility studies and methods including DSC, FT-IR, XRD, and SEM.
View Article and Find Full Text PDFFates of bioactive compounds and antioxidant activities of red pitaya pulp upon in vitro gastrointestinal digestion.
Food Res Int
January 2025
Sericultural & Agri-Food Research Institute, Guangdong Academy of Agricultural Sciences, Key Laboratory of Functional Foods, Ministry of Agriculture and Rural Affairs, Guangdong Key Laboratory of Agricultural Products Processing, Guangdong 510610, China. Electronic address:
Health benefit effects of bioactive compounds depend on their bioavailabilities, which could vary according to factors including food matrix and digestion environment. To understand the "bioaccessible" health benefit of red pitay pulp, the INFOGEST static in vitro simulation of gastrointestinal (GI) digestion model and targeted metabolomics method were applied to unravel the fates of bioactive compounds in the whole food of red pitaya pulp during GI digestion. The antioxidant activity as one of the health benefit indices was also assessed to compare the changes in bioactive properties of red pitaya pulp.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!